STANDARDIZATION OF THE ANTIMENINGITIS SERUM by Jobling, James W.
STANDARDIZATION  OF  THE  ANTIMENINGITIS
SERUM.'
BY  JAMES  W.  JOBLING,  M.D.
(From the  Laboratories of  the  Rockefeller  Institute for Medical
Research, New  York.)
The difficulties  encountered  in standardizing the bactericidal  type
of immune  sera  are great  and  have  not yet  been  successfully  mas-
tered.  They are  especially  great  in  the  case  of the  antimeningitis
serum  in which bacteriolytic  power  cannot  be  utilized as  a measure
of strength and protective and curative  effects,  and the experimental
Diplococcus  intracellularis  infections  in  lower  animals  are  also
unavailable.  The  diplococcus  of  meningitis  is  not  brought  to
bacteriolysis  by the  immune  serum  through  amboceptor  and  com-
plement, and the high variability in pathogenic power of its cultures
makes  the results  of experimental  inoculations  very untrustworthy.
The fatal dose of cultures  and of autolyzed  toxines fluctuate  within
wide limits for animals  (guinea-pigs)  of the same age and  weight.
The attempt to estimate  quantitatively the strength of the antiserum
by means  of complement  deviation cannot be said to have been suc-
cessful,2 and  in  our  hands  has  not  yielded  accurate  or  uniform
results.
The study of the changes which take place,  under the  influence of
the antiserum,  in inoculated  animals and in human  beings  suffering
from epidemic  cerebro-spinal meningitis indicates  unmistakably that
the  antiserum  possesses  power to  destroy  directly  the  diplococcus,
to  neutralize  a  certain  amount  of  the  endotoxin  yielded  by  the
organism,  and  above  all  to  bring  about  an  increased  phagocytic
inclusion  and  digestion  of  the  diplococcus.  The  first  convincing
proof of the manner of action of the antiserum  was  supplied by the
studies  of  Flexner3 carried  out  on  monkeys  in  which  an  experi-
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mental cerebro-spinal  meningitis had been produced by direct inocu-
lation  of the spinal  membranes  with cultures  of  Diplococcus  intra-
cellularis.  In  brief,  Flexner  found  that  in  monkeys  receiving  a
lethal  dose  of  the  culture  an  inflammation  quickly  set  in  and  the
diplococci  appeared partly  free in the fluid exudate and partly within
leucocytes  quite  as  in the natural  disease  in  man.  In  the  animals
not injected  with  the antiserum  the  conditions  remained  essentially
unaltered  until  death,  except  that  some  multiplication of the  diplo-
cocci  sometimes  seemed to take place.  In the animals receiving the
antiserum, the diplococci  diminished  in number, tended to be entirely
taken up by leucocytes,  and to  suffer rapid degeneration  within the
latter.  These  findings  led  to  the  view  that  part  of  the  beneficial
action of the antiserum was due to the increased  phagocytosis  caused
by  it,  a  conclusion  which  has  since  been  verified  in  the  study  of
many  cases  of  epidemic  meningitis  in  human  beings  which  were
treated  with  the  antiserum.4
It should  be mentioned  that  Jochmann5 and  Kolle and Wasser-
manno reported  uniform  results  of tests with  the antiserum  in pro-
tecting  small  animals-mice  or  guinea-pigs-from  the  living  cul-
tures  and thought  that use could  be  made of this  method of stand-
ardization.  But  a  critical  examination  of  their  figures  will  soon
dispel all confidence  in its usefulness although they indicate  a greater
power of the immune serum to protect animals  than is  possessed  by
normal serum.  A similar conclusion  was independently  reached  by
Flexner.7
Jochmann,8 on the other hand, pointed out first that the antiserum
possessed greater  power  of  stimulating  phagocytosis  in  vitro than
normal serum,  thus  bringing it into  line  with other  immune  sera  in
respect  to  opsonic  properties,  but  he  did  not  attempt  to determine
the limits of the opsonic power.
It is difficult  to express  an opinion on the highly divergent results
of Ruppel° who claims  to have  secured  a strain  of  the  diplococcus
'Flexner  and Jobling,  loc. cit.
'Jochmann,  Det.  med.  Woch.,  1907,  xxxii,  788.
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that is uniformly  fatal to mice  in doses  of  I cubic centimeter  of a
I  to  i,ooo,ooo  dilution,  and  employs  this  culture  in  standardizing
an antiserum.  I believe that  in the present  state of our knowledge
of  Diplococcus  intracellularis,  we are  justified  in viewing  Ruppel's
claims with  suspicion.
Kraus and  Doerr10 are the latest writers to recommend  the use of
soluble  products  of  the  diplococcus,  prepared  either  by  Flexner's
toluol  method"  or by  extraction  with  N/Io  sodium  hydrate,  for
standardization  and  determination  of  anti-endotoxic  power of  the
antiserum.  The figures  given by them do not inspire confidence  in
the method.
My  own experiments  with extracts prepared  by autolysis  and by
alkali  extraction have  been  entirely  disappointing.  In the effort  to
secure more uniform  results the proteids were precipitated  from the
extracts with alcohol, dried,  redissolved in sodium chloride solution,
reprecipitated  and  dried.  The  resulting  powder  readily  dissolved
in water and salt solution but acted irregularly whether administered
by  subcutaneous  intraperitoneal  or intracardiac injection  in guinea-
pigs weighing from 200 to 225 grams,  which is the most uniformly
susceptible  size.  The  fatal  dose varied  from  o.ooI  to  o.oI  gram.
I  am  convinced  that nothing  is  to be achieved  by  this  method  of
standardization.
The  methods  which  have  been  worked  out  recently  for  deter-
mining  quantitatively  the  opsonins  in  serum  offer  more  hope  in
securing  a unit  of value  for standardization,  especially  since  it has
been  established  that  the  opsonic  power  of  the  antiserum  is  an
important  factor  in respect to  the therapeutic  effects.  Neufeld12  is
the  first  person  to  make  quantitative  estimations  of  the  opsonic
strength of antimeningitis  sera and to publish his results.  He tested
several  different  samples  of  antimeningitis  sera  to  determine  the
greatest  dilutions  at  which  they  would  still  cause  phagocytosis.
The limits of variation were considerable:  some samples  were active
in  dilutions  of  0.0002  to  0o.oo0005  per  cubic  centimeter  and  others
only on o.oI  per cubic  centimeter.
"0  Kraus  and  Doerr,  Wien. kin. Woch.,  i9o8, xxi,  12.
"Flexner,  Jour. of Exper. Med.,  90o7,  ix,  105.
'Neufeld,  Med. Klin.,  9o8,  iv,  1158.
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Neufeld is strongly of the opinion that the favorable  action of the
antimeningitis  serum  depends  largely  on its bacteriolytic  effect and
hence  he believes  that a measure  of  the  opsonins  would  also  be  a
measure of  its  activity and  would  suffice  for standardization.  He
also  admits  other  effects  of the serum  including  an anti-endotoxic
property but he regards them as subordinate to the opsonic property.
I  used,  at first,  in the quantitative  study  of the  opsonins  of  our
antiserum the  method  recommended  by  Neufeld,  but later  I added
to it  the  direct  method  of  counting  the  included  diplococci  by  a
modified  Leishman's method.  I shall describe  the two methods  em-
ployed  in brief  and then  state the results obtained.
Neufeld's Method.-The leucocytes  are obtained  from  the  peri-
toneal  cavity of guinea-pigs by injecting aleuronat  one day and col-
lecting  the exudate the next day.  The cells are washed four times
in o.9 per cent. salt solution.  After the last washing they are sus-
pended in such  a quantity of the saline solution as to equal in opacity
a 0.3  per cent.  lecithin  emulsion  in normal  saline.
The  emulsion  of diplococcus  is  made  by adding one cubic  centi-
meter  of  an  equal  mixture  of  bouillon  and  salt  solution  to  each
slanted  tube  of  twenty-four  hours'  growth  of  the  diplococcus  on
beef-infusion-glucose  agar.  This  emulsion  is  quite  thick  but  it  is
desirable  that it should  be.
Not every culture of diplococcus  intracellularis  is suitable  for the
test.  Neufeld laid great  stress on the proper selection of the  culture
and  my  experience  agrees  with  his.  I  examined  and  discarded
numerous  cultures  as  being  unsuitable  either  for  the  reason  that
they were too readily digested  by the  leucocytes,  or were not readily
subject  to  phagocytic  inclusion.  Culture  No.  720,  which  was  the
one  selected,  fulfilled  the  conditions  very  well.  As illustrating  the
great variation  in phagocytosis  I might mention that certain antisera
caused  considerable  phagocytosis  of  this  culture  in  dilutions  of
I  to  5,000,  while  with  other  cultures  a  corresponding  amount  of
phagocytosis  required  a  dilution  of  I  to  500.  Culture  No.  720
had  been  under  artificial  cultivation  for  more  than  a  year.  But
the  factor  of  artificial  cultivation  is  not  highly  important,  as  I
found  that  certain  recently  isolated  strains were  more  easily  pha-
gocyted  than some  strains grown  in the  laboratory  for three  years.
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The tests are  conducted  in test-tubes of about twelve  millimeters
in diameter  and five centimeters  in length.  To each tube  are added
two drops of the  diluted antiserum, one  drop of emulsion  of  diplo-
coccus  and  two drops  of  suspension  of  leucocytes.  The tubes  are
incubated  at 370  C. for one and  one-half  hours.  At the expiration
of the  incubation  the leucocytes  have  settled  to the bottom  of  the
tubes  so that by  careful  manipulation  the supernatant  fluid  can  be
poured  off,  leaving  the  leucocytes  adherent  to  the  bottom  of  the
tube.  The spreads are made from the mass of leucocytes  and diplo-
cocci  by placing a platinum loopful on  a slide and spreading it with
the  inclined  edge  of a  second  slide.  After  drying  in  the  air,  the
spread  is  fixed  for  one  minute  in  methyl  alcohol  and  then  stained
in  a  I  to  Io dilution  of  Manson's  methylene  blue  solution.  The
control  tube  contains  salt  solution  instead  of  antiserum.  Where
many tests are  being carried  on  at one time a control  tube is  made
for each six or eight of the series.  The serum tested  ranged  in age
from  ten  days  to  fifteen  months.  When  the  sera  were  less  than
fifteen days old they were heated  at 60° C. for thirty minutes before
testing.
The readings  are based  on  the  gross  appearance  of the  spreads
without  counting  the  phagocyted  diplococci.  The  spreads  made
from  the  tubes  containing  the  higher  concentrations  of  the  anti-
serum showed that very marked phagocytosis  had occurred.  Many
of the  leucocytes  were  completely  filled with  diplococci;  the control
spreads  would  sometimes  show  leucocytes  containing two  or three
diplococci.  In dilutions  of the  serum at  I to  I,ooo  and  I to 2,000
no  difficulty  was  experienced  in  interpreting  the  appearance  since
the degree  of phagocytosis  greatly exceeds  the controls.  When the
dilutions exceeded  I  to 2,000 the decision was sometimes  less readily
made.  Whenever  doubt  existed  the  tests  were  repeated  several
times  so  as to avoid  the experimental  error as  far as possible.
Modified Leishman  Method.-Feeling that the  figures  obtained
by the  Neufeld  method were  subject  to some  difference  in interpre-
tation,  all the antisera  were  tested as  follows:  the leucocytes  were
derived  from  the circulating  blood of the  dog, the  emulsion  of the
diplococcus  was  prepared  much  thinner,  and  capillary  tubes  were
used  for  the  mixture  to  be  incubated,  after  the  manner  recom-
Leishman,  Brit. Med. Jour.,  902,  i, 73.
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mended  by  Leishman.  The  included  cocci  were  counted  and  the
greatest dilution  yielding a higher count than the saline control  was
taken  as representing  the ultimate  strength  of the  antiserum.
The figures  yielded  by the  two methods  are  in remarkable  agree--
ment so that it will be necessary to give  only one  table showing the
general  results  obtained.  In  practice,  the  second  or  Leishman
method  is  somewhat more  convenient. 14
The two methods were applied to the antisera obtained by mixing
the sera from the  three horses used  for immunization  as is  done  in
preparing  the antiserum  for distribution.  The table gives the num-
bers  of  the sera  tested,  the  numbers  of  the horses  and  the  age of
the antisera  at the time  of the testing.
TABLE  I.
Number of Serum.  .
7
12
I7
I9
20
21
22
23
24
25
26
27
28
29
30
31
32
Normal
horse  serum.
Opsonic Strength of
Hones Used.
Nos.  I  and 2
Nos.  I  and 2
Nos.  I  and 2
Nos.  I  and 2
Nos.  I,  2  and  3
Nos.  I, 2  and  3
Nos.  I,  2  and  3
Nos.  I, 2  and  3
Nos.  2  and  3
Nos.  2  and  3
Nos.  I  and  2
Nos.  I,  2  and 3
Nos.  I,  2 and  3
Nos.  I,  2  and  3
Nos.  I,  2  and  3
Nos.  I, 2  and  3
Nos.  I,  2 and  3
the  Mixed Antisera.
Age of Serum.
I5 months
133  (
IO
9  i
81 
8  "
73  "
7  I  "
61  "
63  " 4  "
3  "
2  "
2½  "
15  days
30 and  60o  days
"I  am  indebted  to  Dr.  R. V. Lamar  for a  slight modification  of  the  methods
which  has  led to more  accurate  results.  Owing  to the  readiness  with  which the
diplococcus  is  dissolved  in  the  leucocytes,  it  is  important  to  leave  them  in  con-
tact  for  the  briefest  possible  period.  By  incubating  the  serum  dilution  and'
diplococci  at 370  C.  for one  hour, before adding  the leucocytes,  and  the mixture-
of  the  three  components  for  an  additional  thirty  minutes,  maximum  phagocy-
tosis  is secured and  the diplococci  are  not so  acted upon  as to lose their staining'
power.
Greatest  Dilution.
I-  800
I-  2,000
I-  2,000
I-  5,000
I-  2,000
I-  2,000
I-  2,000
I-  3,000
I-  1,000
I-  I,000
I-  1,000
I-  800
I-  2,000
I-  5,000
I-  5,000
I-  8,000
1-10,000
I-  80oStandardization of  the  Antimeningitis Serum.
The variations  shown  in the  table may  at first  sight appear  con-
tradictory,  but  on  analysis  they  will  prove  not  to  be  so.  In  the
beginning of the  work on the antimeningitis  serum,  only  one horse
was used  in the preparation of the serum and it was not until several
months  later  that  a  second  horse  was  subjected  to  immunization.
Sera  Nos. 7, I2,  17 and  19 were prepared from a mixture of the sera
of horses  Nos.  I and 2.  The power  rose in this mixed  serum from
I to 8o00 to  to  ,ooo in about six months time.  Somewhat later a
third horse was added,  and  serum No. 20  is the first lot containing
serum from horse  No. 3.
The  drop in opsonic activity  has been  attributed  to the  effect of
serum  from horse  No.  3 that  was of  low strength.  Gradually  the
strength of the mixture rose to  I to 3,000 (sample  No. 23).  Shortly
after the  preparation of  sample  No.  23, the  horse  No.  I developed
fever  which  continued  for several  days  so  that  the  horse  was not
bled  the  next  regular  time.  Hence  serum  (sample  No.  24)  was
composed of sera from horses  Nos.  2 and 3 which  had been treated
a shorter time than  horse  No.  I.  The  drop  in  opsonic  activity  is
marked,  as  the limit of the next  two samples  was  only  to  I,ooo.
After serum No.  25 was prepared  the horses were  sent to the farm
for the summer-from  June until  September,  during which  period
they  received  no  inoculation.  Samples  Nos.  26  and  27  show  the
falling  off  due  to  the  summer's  rest.  Inoculations  were  resumed
and a progressive  increase  in opsonic strength  produced  in the com-
bined sera, the highest titre being reached  in sample No. 32 in which
the limit of dilution was  I to  o,ooo.  The opsonic value  of normal
horse  serum  is low  and  in  the sample  recorded  was  to  80.
TABLE  II.
OPsonic Strength of  the Separate Antisera.
No.  of Serum.  Horse  No.  x  Horse No.  2.  Horse No  3.
No.  26,  Sept.  9,  'o8  I-  2,000  1-I,000  I-  200
No.  28,  Oct.  6,  '08  i-  8,000  1-2,000  I-I,000
No.  29,  Oct.  30,  'o8  1-10,000  I-2,000  -2,000
No.  32,  Jan.  7, '09  I-20,000  I-5,000  1-2,000
Beginning September,  I9o8, the sera from the several horses were
tested  separately  several times.  Table  II  gives  the results of  four
tests of  each  horse  and exhibits  clearly  the  effects  of  inoculations
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continued  over a long period of time.  In  September,  90o8,  Horse
No.  I  had  been  under  treatment  for  two  years;  horse  No.  2  for
fourteen months;  and  horse  No.  3 for eight  months.
The  serum sample of September  9  was drawn before  inoculation
was  re-commenced  after  the  summer's  rest.  Horse  No.  3  has
always  given  a  smaller  yield  of  serum  for  the  amount  of  blood
withdrawn  than either  horse  No. I or No.  2.  Horse No.  I yields
the  greatest  volume  of  serum  of  the  three  horses.  Hence  in  the
mixtures,  the diluting effects  of the sera of horses  Nos.  2  and 3 are
less  than  would  have  been  the case  had  the  yield  of  serum  been
approximately equal.
CONCLUSIONS.
The  high  variability  in  infectivity  of  Diplococcus  intracellularis
makes  it  impracticable  to standardize  the  antimeningitis  serum  on
the basis  of the virulence  of the  diplococcus.
The  irregularity  of  reaction  of  small  animals  to  the  poison  or
endotoxin  of  Diplococcus  intracellularis  makes  it  impracticable  to
standardize  the antimeningitis  serum on the basis of endotoxic value.
The want  of uniformity  in the complement-binding  power of the
antimeningitis  serum,  and  the  absence  of  established  relation  be-
tween  complement-binding  power and  therapeutic  activity make the
employment  of this method of standardization  impracticable.
The part taken  by  specific  opsonins  in promoting  recovery  from
infection with  Diplococcus intracellularis suggests their employment
as a measure of the therapeutic activity of the antiserum.  Methods
of  quantitative  estimation  of  opsonic  content of the antimeningitis
serum being available,  it would seem  advantageous  to adopt  for the
present  as  a  standard  of  value  a  definite  and  suitable  strength  in
opsonins of the antimeningitis  serum.
As  a definite  and  suitable  standard  of  strength  a  minimum  dilu-
tion activity of a I to 5,0oo  dilution of the  antiserum is proposed.
Since  the  immune  opsonins  of  the  antimeningitis  serum  appear
to be  highly durable under proper conditions  of refrigeration  of the
antiserum, the test proposed will be  applicable  when  the antimenin-
gitis serum shall have become an article of commerce.
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